XERS
Xeris Biopharma Holdings, Inc.
$6.79
-2.02%
$1.2B
No data for this timeframe.
Vol
Market Cap$1.2B
Cap SizeSmall Cap
Inst. Holders50 funds
Inst. Value$366.2M
Inst. Activity14 buys / 13 sells
Insider Activity0B / 10S
Insider Net $-$994.5K
SEC Reports6
Recent Activity
Jun 12, 2026
SEC
Six institutional buyers accumulated $3.5M in XERS shares during 2024-Q3, led by quant hedge fund D.E. Shaw which added
INST-CLUSTER — Impact 4/10
Jun 5, 2026
SEC
Two Xeris insiders (Director Persky and officer Hecht) sold a combined $192K in open-market sales over a 3-day window. T
CLUSTER — Impact 3/10
Jun 5, 2026
SEC
A cluster of insider selling at Xeris Biopharma, totaling $192K in open-market sales by two directors and an officer, oc
CLUSTER — Impact 3/10
Jun 4, 2026
Insider
Brady James Aloysius was granted 24,193 shares
Director
Jun 4, 2026
Insider
Brady James Aloysius was granted 32,996 shares
Director @ $6.15 ($202.9K)
Jun 4, 2026
Insider
JOHNSON JOHN sold 15,000 shares
Director @ $6.09 ($91.4K)
Inst.
Legal & General Group — ADD
1,908,289 shares ($11.1M)
Inst.
DRIEHAUS CAPITAL MANAGEMENT LLC — TRIM
902,740 shares ($5.2M)
Price Targets
Historical data — last covering-analyst action Mar 2026. No current recommendation available.
$11.29 (Mar 2026)
Current $6.79
Low $8.00
Median $10.00
High $18.00
7 analysts
$8.00
$18.00
Analyst Ratings
5Strong Buy
6Buy
2Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 2, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| Jan 9, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.00 ▼ -69.0% | $-0.01 — $0.02 | 133% YoY | 3 |
| Next Q | $0.04 ▼ -14.6% | $0.03 — $0.05 | 0% YoY | 4 |
| Current FY | $0.14 | $0.10 — $0.19 | 0% YoY | 4 |
| Next FY | $0.40 ▲ +6.6% | $0.24 — $0.60 | 177% YoY | 4 |
Latest Reports
BULLISH
INST-CLUSTER
4/10
Six institutional buyers accumulated $3.5M in XERS shares during 2024-Q3, led by quant hedge fund D.E. Shaw which added
Jun 12, 2026
NEUTRAL
CLUSTER
3/10
Two Xeris insiders (Director Persky and officer Hecht) sold a combined $192K in open-market sales over a 3-day window. T
Jun 5, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $75.1M | — |
| D. E. Shaw & | $45.2M | ADD |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.5M | — |
| STATE STREET CORP | $27.0M | — |
| Nuveen, LLC | $16.9M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 4, 2026 | Brady James | A | $0.00 |
| Jun 4, 2026 | Brady James | A | $202.9K |
| Jun 4, 2026 | JOHNSON JOHN | SELL | $91.4K |
| Jun 4, 2026 | HALKUFF DAWN | SELL | $121.9K |
| Jun 4, 2026 | JOHNSON JOHN | A | $0.00 |
50 institutional holders with $366.2M total value (62,989,092 shares) as of 2026-Q1. Top holders: BlackRock,, D., VANGUARD. Net buying activity: 14 institutions added/increased vs 13 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 12,945,785 | $75.1M | 20.5% | — |
| 2 | D. E. Shaw & Co., Inc. | 7,788,811 | $45.2M | 12.3% | ADD +29.7% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 6,980,882 | $40.5M | 11.1% | — |
| 4 | STATE STREET CORP | 4,658,174 | $27.0M | 7.4% | — |
| 5 | Nuveen, LLC | 2,916,598 | $16.9M | 4.6% | — |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2,665,608 | $15.5M | 4.2% | — |
| 7 | MORGAN STANLEY | 2,572,654 | $14.9M | 4.1% | — |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 2,171,354 | $12.6M | 3.4% | DOUBLED +293.6% |
| 9 | TWO SIGMA INVESTMENTS, LP | 1,924,202 | $11.2M | 3.0% | — |
| 10 | Legal & General Group Plc | 1,908,289 | $11.1M | 3.0% | ADD +36.7% |
| 11 | GOLDMAN SACHS GROUP INC | 1,613,650 | $9.4M | 2.6% | — |
| 12 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,359,657 | $7.9M | 2.2% | — |
| 13 | VANGUARD FIDUCIARY TRUST CO | 1,133,902 | $6.6M | 1.8% | — |
| 14 | DRIEHAUS CAPITAL MANAGEMENT LLC | 902,740 | $5.2M | 1.4% | TRIM -69.7% |
| 15 | BANK OF AMERICA CORP /DE/ | 874,397 | $5.1M | 1.4% | TRIM -55.0% |
| 16 | FEDERATED HERMES, INC. | 856,813 | $5.0M | 1.4% | — |
| 17 | Trexquant Investment LP | 833,217 | $4.8M | 1.3% | DOUBLED +290.1% |
| 18 | CITADEL ADVISORS LLC | 681,634 | $4.0M | 1.1% | — |
| 19 | VOYA INVESTMENT MANAGEMENT LLC | 625,310 | $3.6M | 1.0% | ADD +36.4% |
| 20 | DEUTSCHE BANK AG\ | 623,012 | $3.6M | 1.0% | TRIM -33.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Legal & General Group Plc | ADD | 1,396,265 | 1,908,289 | +36.7% | $11.1M | 2026-Q1 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | TRIM | 2,980,567 | 902,740 | -69.7% | $5.2M | 2026-Q1 |
| Trexquant Investment LP | DOUBLED | 213,581 | 833,217 | +290.1% | $4.8M | 2026-Q1 |
| VOYA INVESTMENT MANAGEMENT LLC | ADD | 458,329 | 625,310 | +36.4% | $3.6M | 2026-Q1 |
| DEUTSCHE BANK AG\ | TRIM | 940,592 | 623,012 | -33.8% | $3.6M | 2026-Q1 |
| SEI INVESTMENTS CO | ADD | 399,347 | 579,210 | +45.0% | $3.4M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 619,660 | 452,860 | -26.9% | $2.6M | 2026-Q1 |
| Connor, Clark & Lunn Investment Management Ltd. | TRIM | 1,058,692 | 407,625 | -61.5% | $2.4M | 2026-Q1 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | TRIM | 811,129 | 370,116 | -54.4% | $2.1M | 2026-Q1 |
| JANUS HENDERSON GROUP PLC | DOUBLED | 69,887 | 295,489 | +322.8% | $1.7M | 2026-Q1 |
| GROUP ONE TRADING LLC | ADD | 123,561 | 218,145 | +76.5% | $1.3M | 2026-Q1 |
| Swiss Life Asset Management Ltd | ADD | 26,059 | 33,232 | +27.5% | $789.2K | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | TRIM | 214,786 | 133,760 | -37.7% | $775.8K | 2026-Q1 |
| TUDOR INVESTMENT CORP ET AL | DOUBLED | 22,186 | 107,414 | +384.2% | $623.0K | 2026-Q1 |
| FRANKLIN RESOURCES INC | TRIM | 121,428 | 80,217 | -33.9% | $465.3K | 2026-Q1 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | ADD | 45,801 | 72,804 | +59.0% | $422.3K | 2026-Q1 |
| PRUDENTIAL FINANCIAL INC | NEAR_EXIT | 618,949 | 57,139 | -90.8% | $331.4K | 2026-Q1 |
| Pictet Asset Management Holding SA | ADD | 23,196 | 29,999 | +29.3% | $174.0K | 2026-Q1 |
| Rafferty Asset Management, LLC | TRIM | 33,689 | 24,247 | -28.0% | $140.6K | 2026-Q1 |
| STRS OHIO | TRIM | 65,500 | 17,600 | -73.1% | $102.1K | 2026-Q1 |
| Brevan Howard Capital Management LP | NEAR_EXIT | 92,416 | 15,753 | -83.0% | $91.4K | 2026-Q1 |
| CAPTRUST FINANCIAL ADVISORS | ADD | 11,816 | 14,815 | +25.4% | $85.9K | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | ADD | 2,353 | 3,105 | +32.0% | $18.0K | 2026-Q1 |
| Rockefeller Capital Management L.P. | DOUBLED | 594 | 2,964 | +399.0% | $17.2K | 2026-Q1 |
| PNC FINANCIAL SERVICES GROUP, INC. | DOUBLED | 399 | 1,053 | +163.9% | $6.1K | 2026-Q1 |
11 unique insiders with 39 transactions. Net insider value: -$994.5K ($0.00 bought, $994.5K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Brady James Aloysius | Director | AWARD | 24,193 | — | — |
| Jun 4, 2026 | Brady James Aloysius | Director | AWARD | 32,996 | $6.15 | $202.9K |
| Jun 4, 2026 | JOHNSON JOHN | Director | SELL | 15,000 | $6.09 | $91.4K |
| Jun 4, 2026 | HALKUFF DAWN | Director | SELL | 20,000 | $6.09 | $121.9K |
| Jun 4, 2026 | JOHNSON JOHN | Director | AWARD | 24,193 | — | — |
| Jun 4, 2026 | JOHNSON JOHN | Director | AWARD | 32,996 | $6.15 | $202.9K |
| Jun 4, 2026 | HALKUFF DAWN | Director | AWARD | 24,193 | — | — |
| Jun 4, 2026 | HALKUFF DAWN | Director | AWARD | 32,996 | $6.15 | $202.9K |
| Jun 4, 2026 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | SELL | 16,000 | $6.09 | $97.5K |
| Jun 4, 2026 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | AWARD | 24,193 | — | — |
| Jun 4, 2026 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | AWARD | 32,996 | $6.15 | $202.9K |
| Jun 4, 2026 | PERSKY MARLA | Director | AWARD | 24,193 | — | — |
| Jun 4, 2026 | PERSKY MARLA | Director | AWARD | 32,996 | $6.15 | $202.9K |
| Jun 4, 2026 | Kong Garheng | Director | AWARD | 24,193 | — | — |
| Jun 4, 2026 | Kong Garheng | Director | AWARD | 32,996 | $6.15 | $202.9K |
| Jun 3, 2026 | PERSKY MARLA | Director | SELL | 15,500 | $5.90 | $91.4K |
| Jun 1, 2026 | Hecht Beth | See Remarks | SELL | 16,667 | $6.06 | $101.0K |
| May 1, 2026 | Hecht Beth | See Remarks | SELL | 16,667 | $6.23 | $103.8K |
| Apr 1, 2026 | Hecht Beth | See Remarks | SELL | 16,667 | $5.99 | $99.9K |
| Mar 30, 2026 | Brady James Aloysius | Director | SELL | 10,834 | $5.54 | $60.0K |
| Mar 12, 2026 | McCulloch Kevin | See Remarks | EXERCISE | 48,894 | $4.09 | $200.0K |
| Mar 5, 2026 | Pieper Steven | See Remarks | EXERCISE | 27,891 | $4.09 | $114.1K |
| Mar 2, 2026 | Hecht Beth | See Remarks | SELL | 16,567 | $6.24 | $103.4K |
| Feb 24, 2026 | Nguyen Anh Tu | See Remarks | TAX W/H | 29,300 | $6.88 | $201.6K |
| Feb 2, 2026 | Hecht Beth | See Remarks | SELL | 16,667 | $7.45 | $124.1K |
| Jan 31, 2026 | Hecht Beth | See Remarks | TAX W/H | 98,375 | $7.36 | $724.0K |
| Jan 31, 2026 | Pieper Steven | See Remarks | TAX W/H | 111,765 | $7.36 | $822.6K |
| Jan 31, 2026 | McCulloch Kevin | See Remarks | TAX W/H | 68,454 | $7.36 | $503.8K |
| Jan 31, 2026 | Shannon John Patrick Jr | See Remarks | TAX W/H | 118,134 | $7.36 | $869.5K |
| Jan 30, 2026 | Nguyen Anh Tu | See Remarks | AWARD | 162,162 | — | — |
| Jan 30, 2026 | Nguyen Anh Tu | See Remarks | AWARD | 121,293 | — | — |
| Jan 30, 2026 | Hecht Beth | See Remarks | AWARD | 162,162 | — | — |
| Jan 30, 2026 | Hecht Beth | See Remarks | AWARD | 121,293 | — | — |
| Jan 30, 2026 | Pieper Steven | See Remarks | AWARD | 207,207 | — | — |
| Jan 30, 2026 | Pieper Steven | See Remarks | AWARD | 154,986 | — | — |
| Jan 30, 2026 | McCulloch Kevin | See Remarks | AWARD | 225,225 | — | — |
| Jan 30, 2026 | McCulloch Kevin | See Remarks | AWARD | 168,463 | — | — |
| Jan 30, 2026 | Shannon John Patrick Jr | See Remarks | AWARD | 639,639 | — | — |
| Jan 30, 2026 | Shannon John Patrick Jr | See Remarks | AWARD | 478,436 | — | — |
6 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 5 neutral. Avg impact: 2.8/10.
BULLISH
INST-CLUSTER
4/10
Six institutional buyers accumulated $3.5M in XERS shares during 2024-Q3, led by quant hedge fund D.
Jun 12, 2026
NEUTRAL
CLUSTER
3/10
Two Xeris insiders (Director Persky and officer Hecht) sold a combined $192K in open-market sales ov
Jun 5, 2026
NEUTRAL
CLUSTER
3/10
A cluster of insider selling at Xeris Biopharma, totaling $192K in open-market sales by two director
Jun 5, 2026
NEUTRAL
144
2/10
Director Marla Persky filed a Form 144 notice of intent to sell 15,500 shares of XERS common stock,
Jun 5, 2026
NEUTRAL
144
2/10
Director Dawn Halkuff filed a Form 144 notice of intent to sell 20,000 shares of Xeris Biopharma com
Jun 4, 2026
NEUTRAL
8-K
3/10
Analysis based on filing metadata only — document content was unavailable. The 8-K filing for Xeris
Feb 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Mar 2026): 85% buy across 13 analysts — 5 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Mar 2026. No current recommendation available.
$11.29 mean target (Mar 2026)
$8.00 Low
$18.00 High
| Metric | Value |
|---|---|
| Current Price | $6.79 |
| Target Low | $8.00 |
| Target Mean | $11.29 |
| Target Median | $10.00 |
| Target High | $18.00 |
| # Analysts | 7 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $-0.01 | $0.02 | 133.3% | -69.0% | 1↑ 0↓ | $0.1B | 27.0% | 3 |
| Next Q 2026-09-30 |
$0.04 | $0.03 | $0.05 | 0.0% | -14.6% | 1↑ 1↓ | $0.1B | 36.2% | 4 |
| Current FY 2026-12-31 |
$0.14 | $0.10 | $0.19 | 0.0% | +0.2% | 2↑ 1↓ | $0.4B | 32.2% | 4 |
| Next FY 2027-12-31 |
$0.40 | $0.24 | $0.60 | 177.2% | +6.6% | 2↑ 2↓ | $0.5B | 22.7% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.003 | |
| 7d ago | $0.008 | -0.004 |
| 30d ago | $0.011 | -0.007 |
| 60d ago | $0.007 | -0.003 |
| 90d ago | $0.070 | -0.066 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 2, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| Jan 9, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| May 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Apr 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Mar 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Feb 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% | |
| Jan 1, 2026 | 5 | 6 | 2 | 0 | 0 | 85% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 7, 2026
earnings_calendar
XERS Q1 2026 Earnings Scheduled — 2026-05-07
Mar 2, 2026
earnings_calendar
XERS Q4 2025 Earnings After Market Close — 2026-03-02